Evidence map›Paper›PMID 36190937›Full record

ArticlePloS one2022

Preoperative prediction by artificial intelligence for mastoid extension in pars flaccida cholesteatoma using temporal bone high-resolution computed tomography: A retrospective study.

Masahiro Takahashi, Katsuhiko Noda, Kaname Yoshida, Keisuke Tsuchida, Ryosuke Yui, Takara Nakazawa, Sho Kurihara, Akira Baba, Masaomi Motegi, Kazuhisa Yamamoto and 3 more

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. [Staging of middle ear cholesteatoma surgery and its value for clinical decision-making].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Artificial Intelligence for Otosclerosis Detection: A Pilot Study.Journal of imaging informatics in medicine · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Masahiro TakahashiDepartment of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.ORCID 0000-0002-7286-2326
Katsuhiko NodaSIOS Technology Inc., Tokyo, Japan.
Kaname YoshidaSIOS Technology Inc., Tokyo, Japan.
Keisuke TsuchidaDepartment of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.
Ryosuke YuiDepartment of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.
Takara NakazawaDepartment of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.
Sho KuriharaDepartment of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.
Akira BabaDepartment of Radiology, The Jikei University School of Medicine, Tokyo, Japan.
Masaomi MotegiDepartment of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.ORCID 0000-0003-0947-6526
Kazuhisa YamamotoDepartment of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.
Yutaka YamamotoDepartment of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.
Hiroya OjiriDepartment of Radiology, The Jikei University School of Medicine, Tokyo, Japan.
Hiromi KojimaDepartment of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cholesteatoma is a progressive middle ear disease that can only be treated surgically but with a high recurrence rate. Depending on the extent of the disease, a surgical approach, such as microsurgery with a retroarticular incision or transcanal endoscopic surgery, is performed. However, the current examination cannot sufficiently predict the progression before surgery, and changes in approach may be made during the surgery. Large amounts of data are typically required to train deep neural network models; however, the prevalence of cholesteatomas is low (1-in-25, 000). Developing analysis methods that improve the accuracy with such a small number of samples is an important issue for medical artificial intelligence (AI) research. This paper presents an AI-based system to automatically detect mastoid extensions using CT. This retrospective study included 164 patients (80 with mastoid extension and 84 without mastoid extension) who underwent surgery. This study adopted a relatively lightweight neural network model called MobileNetV2 to learn and predict the CT images of 164 patients. The training was performed with eight divided groups for cross-validation and was performed 24 times with each of the eight groups to verify accuracy fluctuations caused by randomly augmented learning. An evaluation was performed by each of the 24 single-trained models, and 24 sets of ensemble predictions with 23 models for 100% original size images and 400% zoomed images. Fifteen otolaryngologists diagnosed the images and compared the results. The average accuracy of predicting 400% zoomed images using ensemble prediction model was 81.14% (sensitivity = 84.95%, specificity = 77.33%). The average accuracy of the otolaryngologists was 73.41% (sensitivity, 83.17%; specificity, 64.13%), which was not affected by their clinical experiences. Noteworthily, despite the small number of cases, we were able to create a highly accurate AI. These findings represent an important first step in the automatic diagnosis of the cholesteatoma extension.

Indexed as

Cholesteatoma, Middle EarMastoidArtificial IntelligenceHumansRetrospective StudiesTemporal BoneTomography, X-Ray Computed

Identifiers

PMID36190937
PMCPMC9529134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.